vs
Side-by-side financial comparison of Global Business Travel Group, Inc. (GBTG) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $792.0M, roughly 1.9× Global Business Travel Group, Inc.). Global Business Travel Group, Inc. runs the higher net margin — 10.5% vs 4.4%, a 6.0% gap on every dollar of revenue. On growth, Global Business Travel Group, Inc. posted the faster year-over-year revenue change (34.0% vs 32.8%). BeOne Medicines Ltd. produced more free cash flow last quarter ($379.8M vs $13.0M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 13.9%).
A travel management company (TMC) is a travel agency which manages organizations' corporate or business travel programs. Such companies will often provide an end-user online booking tool, mobile application, program management, and consulting teams, executive travel services, meetings and events support, reporting functionality, duty of care, and more. Non-Profit travel management companies also provide services to manage complex visa requirements, pre-trip medical needs, remote area travel, ...
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
GBTG vs ONC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $792.0M | $1.5B |
| Net Profit | $83.0M | $66.5M |
| Gross Margin | — | 90.5% |
| Operating Margin | 3.7% | 12.4% |
| Net Margin | 10.5% | 4.4% |
| Revenue YoY | 34.0% | 32.8% |
| Net Profit YoY | 692.9% | 143.8% |
| EPS (diluted) | $0.16 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $792.0M | $1.5B | ||
| Q3 25 | $674.0M | $1.4B | ||
| Q2 25 | $631.0M | $1.3B | ||
| Q1 25 | $621.0M | $1.1B | ||
| Q4 24 | $591.0M | $1.1B | ||
| Q3 24 | $597.0M | $1.0B | ||
| Q2 24 | $625.0M | $929.2M | ||
| Q1 24 | $610.0M | $751.7M |
| Q4 25 | $83.0M | $66.5M | ||
| Q3 25 | $-62.0M | $124.8M | ||
| Q2 25 | $15.0M | $94.3M | ||
| Q1 25 | $75.0M | $1.3M | ||
| Q4 24 | $-14.0M | $-151.9M | ||
| Q3 24 | $-128.0M | $-121.3M | ||
| Q2 24 | $27.0M | $-120.4M | ||
| Q1 24 | $-19.0M | $-251.2M |
| Q4 25 | — | 90.5% | ||
| Q3 25 | — | 86.1% | ||
| Q2 25 | — | 87.5% | ||
| Q1 25 | — | 85.2% | ||
| Q4 24 | — | 85.8% | ||
| Q3 24 | — | 83.0% | ||
| Q2 24 | — | 85.1% | ||
| Q1 24 | — | 83.4% |
| Q4 25 | 3.7% | 12.4% | ||
| Q3 25 | 1.8% | 11.5% | ||
| Q2 25 | 5.4% | 6.7% | ||
| Q1 25 | 8.9% | 1.0% | ||
| Q4 24 | 5.1% | -7.0% | ||
| Q3 24 | 4.5% | -12.0% | ||
| Q2 24 | 6.7% | -11.5% | ||
| Q1 24 | 2.6% | -34.8% |
| Q4 25 | 10.5% | 4.4% | ||
| Q3 25 | -9.2% | 8.8% | ||
| Q2 25 | 2.4% | 7.2% | ||
| Q1 25 | 12.1% | 0.1% | ||
| Q4 24 | -2.4% | -13.5% | ||
| Q3 24 | -21.4% | -12.1% | ||
| Q2 24 | 4.3% | -13.0% | ||
| Q1 24 | -3.1% | -33.4% |
| Q4 25 | $0.16 | $0.05 | ||
| Q3 25 | $-0.13 | $0.08 | ||
| Q2 25 | $0.03 | $0.06 | ||
| Q1 25 | $0.16 | $0.00 | ||
| Q4 24 | $-0.04 | $-0.10 | ||
| Q3 24 | $-0.28 | $-0.09 | ||
| Q2 24 | $0.06 | $-0.09 | ||
| Q1 24 | $-0.04 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $434.0M | $4.5B |
| Total DebtLower is stronger | $1.4B | $836.4M |
| Stockholders' EquityBook value | $1.6B | $4.4B |
| Total Assets | $4.9B | $8.2B |
| Debt / EquityLower = less leverage | 0.88× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $434.0M | $4.5B | ||
| Q3 25 | $427.0M | $4.0B | ||
| Q2 25 | $601.0M | $2.8B | ||
| Q1 25 | $552.0M | $2.5B | ||
| Q4 24 | $536.0M | $2.6B | ||
| Q3 24 | $524.0M | $2.7B | ||
| Q2 24 | $515.0M | $2.6B | ||
| Q1 24 | $475.0M | $2.8B |
| Q4 25 | $1.4B | $836.4M | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.4B | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.4B | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.6B | $4.4B | ||
| Q3 25 | $1.5B | $4.1B | ||
| Q2 25 | $1.2B | $3.8B | ||
| Q1 25 | $1.1B | $3.5B | ||
| Q4 24 | $1.1B | $3.3B | ||
| Q3 24 | $1.1B | $3.4B | ||
| Q2 24 | $1.2B | $3.4B | ||
| Q1 24 | $1.2B | $3.4B |
| Q4 25 | $4.9B | $8.2B | ||
| Q3 25 | $4.8B | $7.6B | ||
| Q2 25 | $3.9B | $6.3B | ||
| Q1 25 | $3.8B | $5.8B | ||
| Q4 24 | $3.6B | $5.9B | ||
| Q3 24 | $3.8B | $5.8B | ||
| Q2 24 | $3.8B | $5.7B | ||
| Q1 24 | $3.8B | $5.7B |
| Q4 25 | 0.88× | 0.19× | ||
| Q3 25 | 0.91× | — | ||
| Q2 25 | 1.15× | — | ||
| Q1 25 | 1.23× | — | ||
| Q4 24 | 1.32× | — | ||
| Q3 24 | 1.26× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $52.0M | $417.3M |
| Free Cash FlowOCF − Capex | $13.0M | $379.8M |
| FCF MarginFCF / Revenue | 1.6% | 25.4% |
| Capex IntensityCapex / Revenue | 4.9% | 2.5% |
| Cash ConversionOCF / Net Profit | 0.63× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | $104.0M | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.0M | $417.3M | ||
| Q3 25 | $71.0M | $402.6M | ||
| Q2 25 | $57.0M | $263.6M | ||
| Q1 25 | $53.0M | $44.1M | ||
| Q4 24 | $65.0M | $75.2M | ||
| Q3 24 | $85.0M | $188.4M | ||
| Q2 24 | $73.0M | $-95.6M | ||
| Q1 24 | $49.0M | $-308.6M |
| Q4 25 | $13.0M | $379.8M | ||
| Q3 25 | $38.0M | $354.5M | ||
| Q2 25 | $27.0M | $219.8M | ||
| Q1 25 | $26.0M | $-12.3M | ||
| Q4 24 | $33.0M | $-17.3M | ||
| Q3 24 | $59.0M | $54.7M | ||
| Q2 24 | $49.0M | $-205.5M | ||
| Q1 24 | $24.0M | $-465.1M |
| Q4 25 | 1.6% | 25.4% | ||
| Q3 25 | 5.6% | 25.1% | ||
| Q2 25 | 4.3% | 16.7% | ||
| Q1 25 | 4.2% | -1.1% | ||
| Q4 24 | 5.6% | -1.5% | ||
| Q3 24 | 9.9% | 5.5% | ||
| Q2 24 | 7.8% | -22.1% | ||
| Q1 24 | 3.9% | -61.9% |
| Q4 25 | 4.9% | 2.5% | ||
| Q3 25 | 4.9% | 3.4% | ||
| Q2 25 | 4.8% | 3.3% | ||
| Q1 25 | 4.3% | 5.0% | ||
| Q4 24 | 5.4% | 8.2% | ||
| Q3 24 | 4.4% | 13.3% | ||
| Q2 24 | 3.8% | 11.8% | ||
| Q1 24 | 4.1% | 20.8% |
| Q4 25 | 0.63× | 6.28× | ||
| Q3 25 | — | 3.22× | ||
| Q2 25 | 3.80× | 2.79× | ||
| Q1 25 | 0.71× | 34.71× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.70× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GBTG
| Travel | $620.0M | 78% |
| Other | $172.0M | 22% |
ONC
Segment breakdown not available.
